X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23029) 23029
Publication (1368) 1368
Newsletter (866) 866
Book Review (590) 590
Magazine Article (450) 450
Newspaper Article (120) 120
Book Chapter (111) 111
Book / eBook (67) 67
Conference Proceeding (43) 43
Transcript (34) 34
Trade Publication Article (17) 17
Web Resource (12) 12
Reference (10) 10
Dissertation (8) 8
Paper (3) 3
Report (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19103) 19103
anticonvulsants - adverse effects (11945) 11945
female (11207) 11207
anticonvulsants - therapeutic use (10909) 10909
male (10506) 10506
epilepsy (8362) 8362
index medicus (7921) 7921
clinical neurology (7820) 7820
adult (7375) 7375
epilepsy - drug therapy (7186) 7186
anticonvulsants (6741) 6741
middle aged (4709) 4709
seizures (4618) 4618
adolescent (4480) 4480
child (4287) 4287
antiepileptic drugs (3849) 3849
animals (3511) 3511
anticonvulsants - administration & dosage (3352) 3352
treatment outcome (3220) 3220
pharmacology & pharmacy (3145) 3145
neurosciences (2953) 2953
neurology (2869) 2869
aged (2831) 2831
psychiatry (2631) 2631
carbamazepine (2415) 2415
child, preschool (2398) 2398
anticonvulsants - pharmacology (2268) 2268
drug therapy, combination (2256) 2256
drug therapy (2236) 2236
dose-response relationship, drug (2224) 2224
pregnancy (2137) 2137
children (2080) 2080
seizures - drug therapy (2028) 2028
drugs (2015) 2015
double-blind (1818) 1818
analysis (1805) 1805
valproic acid - adverse effects (1682) 1682
risk factors (1668) 1668
infant (1641) 1641
pediatrics (1619) 1619
lamotrigine (1583) 1583
carbamazepine - adverse effects (1560) 1560
drug interactions (1560) 1560
anticonvulsants - pharmacokinetics (1537) 1537
care and treatment (1528) 1528
young adult (1509) 1509
retrospective studies (1476) 1476
rats (1471) 1471
phenytoin (1468) 1468
electroencephalography (1357) 1357
valproic acid (1348) 1348
mice (1319) 1319
valproic acid - therapeutic use (1318) 1318
efficacy (1314) 1314
phenytoin - adverse effects (1277) 1277
research (1216) 1216
therapy (1192) 1192
carbamazepine - therapeutic use (1179) 1179
epilepsies, partial - drug therapy (1152) 1152
topiramate (1149) 1149
time factors (1097) 1097
fructose - analogs & derivatives (1085) 1085
infant, newborn (1083) 1083
medicine, general & internal (1082) 1082
pharmacokinetics (1077) 1077
medicine & public health (1063) 1063
follow-up studies (1054) 1054
piracetam - analogs & derivatives (1023) 1023
levetiracetam (1015) 1015
health aspects (992) 992
anticonvulsant (963) 963
prospective studies (941) 941
valproate (933) 933
status epilepticus (921) 921
double-blind method (910) 910
epilepsy - complications (891) 891
anticonvulsants - blood (890) 890
complications and side effects (887) 887
behavioral sciences (871) 871
drug administration schedule (847) 847
gabapentin (827) 827
epilepsy - physiopathology (809) 809
disease models, animal (806) 806
risk (787) 787
triazines - adverse effects (782) 782
aged, 80 and over (771) 771
triazines - therapeutic use (761) 761
bipolar disorder - drug therapy (756) 756
dosage and administration (750) 750
sodium valproate (729) 729
phenytoin - therapeutic use (713) 713
medical research (710) 710
pregnancy complications - drug therapy (692) 692
seizures - chemically induced (681) 681
safety (678) 678
age factors (673) 673
epilepsy - diagnosis (672) 672
seizures - etiology (671) 671
drug resistance (667) 667
clinical trials (661) 661
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22412) 22412
German (548) 548
French (402) 402
Spanish (355) 355
Japanese (233) 233
Russian (123) 123
Italian (86) 86
Polish (73) 73
Danish (63) 63
Dutch (61) 61
Norwegian (59) 59
Chinese (46) 46
Portuguese (46) 46
Hungarian (40) 40
Swedish (24) 24
Czech (22) 22
Finnish (19) 19
Croatian (13) 13
Hebrew (12) 12
Romanian (9) 9
Serbian (7) 7
Turkish (6) 6
Korean (5) 5
Bosnian (4) 4
Bulgarian (4) 4
Slovak (3) 3
Ukrainian (3) 3
Arabic (2) 2
Lithuanian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, Pharmacology - research, safety testing and regulation, ISBN 1629480630
Web Resource
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 04/2019, Volume 136, pp. 56 - 63
Journal Article
Current Psychiatry Reports, ISSN 1523-3812, 8/2015, Volume 17, Issue 8, pp. 1 - 10
Journal Article
JAMA Dermatology, ISSN 2168-6068, 09/2014, Volume 150, Issue 9, pp. 984 - 989
Journal Article
Epilepsia, ISSN 0013-9580, 01/2014, Volume 55, Issue 1, pp. 13 - 15
Journal Article
CNS Neuroscience & Therapeutics, ISSN 1755-5930, 10/2011, Volume 17, Issue 5, pp. 490 - 505
SUMMARY Introduction: Central neurochemical systems including the monoamine, opioid, and cannabinoid systems have been promising targets for antiobesity drugs... 
Drugs | Psychological | Topiramate | Antiobesity drugs | Central | Lorcaserin | Sedation | Sibutramine | Naltrexone | Ecopipam | Zonisamide | Bupropion | Adverse events | Cannabinoid receptor | Antiobesity | Anxiety | μ‐opioid receptor | Treatments | Obesity | Depression | Psychiatric | Side effects | Tesofensine | Sleep | Rimonabant | CB1 receptor | Taranabant | Contrave | μ-opioid receptor | receptor | CB1 CANNABINOID RECEPTORS | RANDOMIZED CONTROLLED-TRIAL | CARDIOMETABOLIC RISK-FACTORS | ENERGY-BALANCE | TYPE-2 DIABETIC-PATIENTS | PHARMACOLOGY & PHARMACY | BINGE-EATING DISORDER | WEIGHT-LOSS | NEUROSCIENCES | mu-opioid receptor | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | NALTREXONE TREATMENT | Mental Disorders - chemically induced | Obesity - drug therapy | Dopamine Antagonists - pharmacokinetics | Humans | Mental Disorders - metabolism | Anti-Obesity Agents - adverse effects | Obesity - metabolism | Mental Disorders - psychology | Animals | Anti-Obesity Agents - pharmacokinetics | Central Nervous System Stimulants - adverse effects | Central Nervous System Stimulants - pharmacokinetics | Dopamine Antagonists - adverse effects | Weight reducing preparations | Complications and side effects | Anticonvulsants | Insomnia | Depression, Mental | Food habits | Trademarks | Neurochemistry | Emotional behavior | Opioid receptors | Central nervous system | Cognitive ability | Drug delivery | Sleep disorders | Cannabinoids | Mood | Opioids | zonisamide | bupropion | monoamines | topiramate
Journal Article
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, ISSN 1008-8830, 04/2015, Volume 17, Issue 4, p. 414
Oxcarbazepine is a new antiepileptic drug. The results of clinical trials suggest that oxcarbazepine is well tolerated and has less drug interactions. It is... 
Hyponatremia - chemically induced | Anticonvulsants - adverse effects | Carbamazepine - adverse effects | Carbamazepine - analogs & derivatives | Exanthema - chemically induced | Humans
Journal Article
Journal Article